News
Pharmaron press announcements, major events, achievements and updates
New Website Launched
Beijing, China, November 16, 2023 Pharmaron launched its new website, which includes 180 service descriptions across three modalities: small molecules,…
Pharmaron invests £151M into UK Gene Therapy CDMO with support from UK Government Grant
Beijing, China, MARCH 29, 2023 – Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that their Liverpool, UK-based…
Pharmaron Acquires Commercial API Manufacturing Facility in the United States
Beijing, China, May 24, 2022 – Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has entered…
Pharmaron Appoints Dr. Antony Davies as Senior Vice President, UK CMC
Beijing, China, January 17, 2022 – Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) today announced the appointment of Dr. Antony…
Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm
Continues to strengthen the global chemistry and manufacturing capabilities and capacities Beijing, China, January 10, 2022 – Pharmaron Beijing Co., Limited…
Pharmaron Announces Promotion of Dr. Sid Bhoopathy to Senior Vice President, US Head of Laboratory Services and CGT
Beijing, China, January 7, 2022 – Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) today announced the appointment of Dr. Sid…